Review

Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas

Natalia Genere, Victor Manuel Montori

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)JC8
JournalAnnals of Internal Medicine
Volume168
Issue number2
DOIs
StatePublished - Jan 16 2018

Fingerprint

Costs and Cost Analysis
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Review : Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas. / Genere, Natalia; Montori, Victor Manuel.

In: Annals of Internal Medicine, Vol. 168, No. 2, 16.01.2018, p. JC8.

Research output: Contribution to journalComment/debate

@article{a17724fe5064439a89eae53ed481486e,
title = "Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas",
author = "Natalia Genere and Montori, {Victor Manuel}",
year = "2018",
month = "1",
day = "16",
doi = "10.7326/ACPJC-2018-168-2-008",
language = "English (US)",
volume = "168",
pages = "JC8",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",

}

TY - JOUR

T1 - Review

T2 - Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas

AU - Genere, Natalia

AU - Montori, Victor Manuel

PY - 2018/1/16

Y1 - 2018/1/16

UR - http://www.scopus.com/inward/record.url?scp=85044415384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044415384&partnerID=8YFLogxK

U2 - 10.7326/ACPJC-2018-168-2-008

DO - 10.7326/ACPJC-2018-168-2-008

M3 - Comment/debate

VL - 168

SP - JC8

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 2

ER -